Marginal changes at bone‐level implants supporting dental prostheses with or without intermediate standardised abutments after 36 months: Randomised controlled clinical trial
Clinical Oral Implants Research · 2024
DOI: 10.1111/clr.14297 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Oral Implants Research, 2024. Verfasst von Lucía Maceiras und 6 weiteren Autor:innen. Beteiligte Einrichtung: Periodontology Unit, School of Medicine and Dentistry, University of Santiago de Compostela, Santiago de Compostela, Spain. Hauptthemen laut MEDLINE: Dental Prosthesis, Implant-Supported, Dental Abutments, Alveolar Bone Loss. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ticare®, Mozo-Grau S.A., Valladolid, Spain.
Abstract (Originalsprache)
Objective
The objective of this study is to evaluate the changes at marginal bone level at implants restored with screw‐retained prosthesis connected directly to the implants or with an intermediate abutment, after 3‐year follow‐up. Material and Methods Thirty‐six partially edentulous patients received 72 implants. Each patient received 2 implants and a 2–4‐unit screw‐retained implant‐prosthesis. The test group implants received a screw‐retained prosthesis connected directly to the implant shoulder, the control group prosthesis were connected through a 3‐mm standardised intermediate abutment. Clinical and radiological data were recorded at baseline and at 6‐, 12‐, and 36‐month follow‐up.
Results
At 36 months, the mean marginal bone loss was 0.13 ± 0.18 mm for the control group and 0.20 ± 0.24 for the test group, with no significant differences between groups ( p > .05). Clinical variables (Probing Pocket Depth, Bleeding on Probing and Plaque Index) at 36 months also showed no significant difference between groups. Minor complications frequency was 6.7% in the control group and 5.3% in test group. None of the groups suffered from mayor complications. Patient Reported Outcomes (PROs) showed a General Satisfaction mean score in the control group of 9.40 (SD 0.82) and 9.37 (SD 1.06) in the test group with no significant differences between groups.
Conclusions
Bone‐level implants restored with screw‐retained partial prostheses with or without intermediate abutments showed similar radiographic and clinical outcomes after 3 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Periodontology Unit, School of Medicine and Dentistry, University of Santiago de Compostela, Santiago de Compostela, Spain.
- Medical-Surgical Odontology (OMEQUI) Research Group, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
- Lab Technician, Lugo, Spain.
ORCID-Profile: Lucía Maceiras, Antonio Liñares, Lourdes Nóvoa, Pilar Batalla, Santiago Mareque, Juan Blanco
Förderung
- Ticare®, Mozo-Grau S.A., Valladolid, Spain
Zitieren
APA
Maceiras, L., Liñares, A., Nóvoa, L., Batalla, P., Mareque, S., Pérez, J., & Blanco, J. (2024). Marginal changes at bone‐level implants supporting dental prostheses with or without intermediate standardised abutments after 36 months: Randomised controlled clinical trial. Clinical Oral Implants Research. https://doi.org/10.1111/clr.14297
Vancouver
Maceiras L, Liñares A, Nóvoa L, Batalla P, Mareque S, Pérez J, et al. Marginal changes at bone‐level implants supporting dental prostheses with or without intermediate standardised abutments after 36 months: Randomised controlled clinical trial. Clinical Oral Implants Research. 2024. doi:10.1111/clr.14297
BibTeX
@article{Maceiras2024,
author = {Maceiras, Lucía and Liñares, Antonio and Nóvoa, Lourdes and Batalla, Pilar and Mareque, Santiago and Pérez, Javier and Blanco, Juan},
title = {Marginal changes at bone‐level implants supporting dental prostheses with or without intermediate standardised abutments after 36 months: Randomised controlled clinical trial},
journal = {Clinical Oral Implants Research},
year = {2024},
doi = {10.1111/clr.14297}
}
EUVIMED